Can earlier biomarker measurements explain a treatment effect on diabetes incidence? A robust comparison of five surrogate markers

INTRODUCTION: We measured and compared five individual surrogate markers—change from baseline to 1 year after randomization in hemoglobin A1c (HbA1c), fasting glucose, 2-hour postchallenge glucose, triglyceride–glucose index (TyG) index, and homeostatic model assessment of insulin resistance (HOMA-I...

Descripción completa

Detalles Bibliográficos
Autores principales: Parast, Layla, Tian, Lu, Cai, Tianxi, Palaniappan, Latha P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Epidemiology/Health services research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619035/
https://www.ncbi.nlm.nih.gov/pubmed/37907279
http://dx.doi.org/10.1136/bmjdrc-2023-003585

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619035/
https://www.ncbi.nlm.nih.gov/pubmed/37907279
http://dx.doi.org/10.1136/bmjdrc-2023-003585

Ejemplares similares